alpha-synuclein Archives - European Biotechnology Magazine

Tag Archive for: alpha-synuclein

Alpha-Synuclein staining of a Lewy body in the substantia nigra in Parkinson's disease.

Novartis invests US$200min lacklustre Parkinson’s target

Swiss pharma major Novartis AG is investing money in the inhibition of the Parkinson’s target alpha-synuclein, which has already failed several times in clinical trials. The Swiss company is licensing the siRNA programme ARO-SNCA from Arrowhead Pharmaceuticals for US$200m.